WADAs 2026 Prohibited List includes growth hormone releasing factors and secretagogues such as CJC-1295, Sermorelin, Tesamorelin, Ibutamoren/MK-677, and Ipamorelin
The cardiometabolic benefits can be summarized as follows: decrease in body weight and fat mass, improvement of insulin sensitivity, decrease in blood pressure, lipid-lowering effect, and decrease in the level of serum inflammatory markers (Johnson et al.,
caution is also warranted with anticoagulants, oral contraceptives, and other GLP-1 receptor agonists
Peptide reconstitution fluid is best for sensitive peptides requiring sterile-only environments
The Influence and Mechanism of GLP-1 RAs in Improving Diabetic Cardiopathy At present, diabetic cardiopathy is acknowledged as a condition defined by cardiac dysfunction resulting from aberrant cardiac structure and function in diabetic patients, irrespective of other cardiac risk factors